公开(公告)号：EP2514740A1

公开(公告)日：2012-10-24

申请号：EP12176584.6

申请日：2008-03-13

申请人： Auspex Pharmaceuticals, Inc.

发明人： Gant, Thomas. G ,  Sepher, Sarshar ,  Woo, Soon, Hyung

IPC分类号： C07C217/74 ,  C07C215/64 ,  C07D265/16 ,  C07B59/00

CPC分类号： C07C211/64 ,  C07B59/00 ,  C07B2200/05 ,  C07B2200/07 ,  C07B2200/13 ,  C07C215/64 ,  C07C217/74 ,  C07C2601/14 ,  C07D265/16

摘要： Chemical syntheses and medical uses of novel inhibitors of the uptake of monoamine neurotransmitters and pharmaceutically acceptable salts and prodrugs thereof, for the treatment and/or management of psychotropic disorders, anxiety disorder, generalized anxiety disorder, depression, post-traumatic stress disorder, obsessive-compulsive disorder, panic disorder, hot flashes, senile dementia, migraine, hepatopulmonary syndrome, chronic pain, nociceptive pain, neuropathic pain, painful diabetic retinopathy, bipolar depression, obstructive sleep apnea, psychiatric disorders, premenstrual dysphoric disorder, social phobia, social anxiety disorder, urinary incontinence, anorexia, bulimia nervosa, obesity, ischemia, head injury, calcium overload in brain cells, drug dependence, attention deficit hyperactivity disorder, fibromyalgia, irritable bowel syndrome, and/or premature ejaculation are described.

摘要翻译： 用于治疗和/或处理精神障碍，焦虑症，广泛性焦虑症，抑郁症，创伤后应激障碍，强迫症的神经递质的新型单胺神经递质抑制剂及其药学上可接受的盐和前药的化学合成和医学用途， 惊恐障碍，潮热，老年性痴呆，偏头痛，肝肺综合征，慢性疼痛，伤害性疼痛，神经性疼痛，痛性糖尿病性视网膜病，双相抑郁症，阻塞性睡眠呼吸暂停，精神病，经前烦躁症，社交恐惧症，社交焦虑症 ，尿失禁，厌食症，神经性贪食症，肥胖症，缺血，头部损伤，脑细胞中的钙超载，药物依赖性，注意力缺陷多动症，纤维肌痛，肠易激综合征和/或早泄。